Breaking News Instant updates and real-time market news.

AAPL

Apple

$156.00

-0.55 (-0.35%)

, QCOM

Qualcomm

$53.00

-1.12 (-2.07%)

12:44
10/13/17
10/13
12:44
10/13/17
12:44

Apple dips after Qualcomm asks China to halt iPhone sales

Shares of Apple (AAPL) moved lower after Qualcomm (QCOM), according to Bloomberg, filed lawsuits in China seeking to ban the sale and manufacture of iPhones in the country. Qualcomm filed suits in a Beijing intellectual property court claiming patent infringement and seeking injunctive relief, a spokeswoman for the chipmaker told Bloomberg. "Apple employs technologies invented by Qualcomm without paying for them," Qualcomm spokeswoman Christine Trimble said. Shares of Apple are off the day's highs but remain up 80c to $156.80 in afternoon trading. Qualcomm is up 1c to $53.01.

AAPL

Apple

$156.00

-0.55 (-0.35%)

QCOM

Qualcomm

$53.00

-1.12 (-2.07%)

  • 22

    Oct

  • 02

    Nov

AAPL Apple
$156.00

-0.55 (-0.35%)

10/11/17
PIPR
10/11/17
NO CHANGE
Target $196
PIPR
Overweight
Piper teen survey shows Apple remains dominant brand
Piper Jaffray analyst Michael Olson says his firm's s bi-annual teen survey shows Apple's place as the dominant device brand among teens remains intact. Of the over 6,000 teens surveyed, 78% have an iPhone, up from 76% in the spring, and 82% anticipate their next phone to be an iPhone, Olson tells investors in a research note. The Apple Watch was the top smartwatch among teens, garnering 12%, with the Samsung Gear next on the list at 2%, the analyst adds. He maintains an Overweight rating on Apple with a $196 price target.
10/11/17
MSCO
10/11/17
NO CHANGE
Target $199
MSCO
Overweight
Apple target raised to $199 on higher U.S. iPhone estimates at Morgan Stanley
Morgan Stanley analyst Katy Huberty said the firm's smartphone survey conducted after Apple's September product launch showed that iPhone retention and "switcher" rates, or the percentage of non-iPhone users expected to move to an iPhone, have increased from the firm's last check in April. Given the new survey data, the firm's estimate of North American iPhone shipments was raised to 74M from 72M units and, keeping the rest of the world unchanged, that drives its global iPhone upgrade forecast to 268M units from 266M. Noting this increased forecast, along with "surprisingly bullish" Apple Watch demand revealed in the survey, Huberty raised her price target on Apple shares to $199 from $194 and keeps an Overweight rating on the stock.
10/12/17
LSCM
10/12/17
NO CHANGE
Target $13
LSCM
Buy
Lake Street checks confirm Apple supply chain issues impacting Himax
Lake Street analyst Jaeson Schmidt says recent channel checks indicate the "well-rumored" supply chain issues at Apple (AAPL) and pushouts at Android manufacturers could create headwinds the rest of this year for Himax Technologies and cause 2018 to be more second half weighted than originally expected. The analyst, while admitting his upgrade of Himax two weeks ago was premature, keeps a Buy rating on the shares. Himax has not lost these sockets, but rather is being impacted by timetable shifts, Schmidt tells investors in a research note. He still believes the 3D sensing market has the potential to drive significant growth for the company longer-term. The analyst lowered his 2017 earnings per share estimate for Himax to 9c from 12c and 2018 estimate to 30c from 38c.
10/13/17
LEHM
10/13/17
NO CHANGE
Target $161
LEHM
Equal Weight
Apple price target raised to $161 from $146 at Barclays
Barclays analyst Mark Moskowitz raised his price target for Apple to $161 while keeping an Equal Weight rating on the shares. Industry and media "noise" over supply chain constraints impacting iPhone AX volumes are likely to persist into the first half of 2018, Moskowitz tells investors in a research note titled "Bring in 'Da Noise, Bring Up 'Da Margin." This should ease by next year's June quarter, however, setting the stage for bigger year-over-year unit growth as well as higher gross margin trends, the analyst adds.
QCOM Qualcomm
$53.00

-1.12 (-2.07%)

09/15/17
NORL
09/15/17
UPGRADE
NORL
Outperform
Qualcomm upgraded to Outperform from Market Perform at Northland
09/15/17
09/15/17
UPGRADE
Target $62.5

Outperform
Qualcomm upgraded to Outperform on 3D sensing opportunity at Northland
As previously reported, Northland analyst Tom Sepenzis upgraded Qualcomm (QCOM) to Outperform from Market Perform on expectations for market share gains in 2018, particularly at the high end, as he sees the company and partner Himax (HIMX) as well positioned to become the "de facto leading 3D sensing solution" with Android manufacturers who follow the lead of Apple's (AAPL) new iPhone X. From what he understands, handset makers that want to use its SLiM structured light solution will have to use Qualcomm's next generation Snapdragon chipset too, he tells investors. Sepenzis keeps a $62.50 price target on Qualcomm shares.
09/15/17
09/15/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Dish (DISH) upgraded to Neutral from Sell at Citi with analyst Jason Bazinet saying the valuation seems fair following the recent weakness in the shares. 2. First Solar (FSLR) upgraded to Buy from Hold at Deutsche Bank with analyst Vishal Shah saying channel checks indicate that "robust" U.S. demand is driving module prices higher. 3. Southwest (LUV) upgraded to Overweight from Neutral at JPMorgan with analyst Jamie Baker saying the recent correction in Southwest shares makes for a "compelling" risk-to-reward profile. 4. Qualcomm (QCOM) upgraded to Outperform from Market Perform at Northland with analyst Tom Sepenzis citing expectations for market share gains in 2018, particularly at the high end, as he sees the company and partner Himax (HIMX) as well positioned to become the "de facto leading 3D sensing solution" with Android manufacturers who follow the lead of Apple's (AAPL) new iPhone X. 5. Harsco (HSC) upgraded to Buy from Hold at Argus with analyst David Coleman saying cost cutting initiatives, returns on prior investments, and improving end market demand have resulted in above Street results in the first half of 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/22/17
RBCM
09/22/17
NO CHANGE
Target $9.5
RBCM
Sector Perform
BlackBerry can use $1.6B of cash on acquisitions, says RBC Capital
RBC Capital analyst Paul Treiber says BlackBerry (BBRY) has $2.36B in cash after the $940M award from Qualcomm (QCOM). The company can use up to $1.6B of the cash on acquisitions, which may be accretive to earnings and the stock price, Treiber tells investors in a research note. He fells an acquisition of a company with organic growth above BlackBerry's targeted 10%-15% software growth "would be a tailwind to BlackBerry's organic growth." Treiber expects in-line Q2 results from BlackBerry on September 28 and keeps a Sector Perform rating on the shares.

TODAY'S FREE FLY STORIES

07:54
02/22/18
02/22
07:54
02/22/18
07:54
Conference/Events
CFA Society of Milwaukee to hold a luncheon discussion »

Bill Stone, CMT of PNC…

07:53
02/22/18
02/22
07:53
02/22/18
07:53
Conference/Events
STAT Plus to hold webinar »

STAT Senior Science…

AAOI

Applied Optoelectronics

$34.55

1.22 (3.66%)

07:51
02/22/18
02/22
07:51
02/22/18
07:51
Recommendations
Applied Optoelectronics analyst commentary  »

Applied Optoelectronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

  • 29

    Mar

07:51
02/22/18
02/22
07:51
02/22/18
07:51
General news
Futures pointing to higher open »

Stock futures have…

07:51
02/22/18
02/22
07:51
02/22/18
07:51
Conference/Events
The FCC to hold a commission meeting »

Open Commission Meeting…

07:50
02/22/18
02/22
07:50
02/22/18
07:50
Conference/Events
Federal Reserve Bank of New York President speaks at press briefing »

New York Federal Reserve…

STMP

Stamps.com

$184.95

-5.1 (-2.68%)

07:49
02/22/18
02/22
07:49
02/22/18
07:49
Recommendations
Stamps.com analyst commentary  »

Stamps.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 11

    Mar

  • 23

    May

LNKD

Acquired by MSFT

07:48
02/22/18
02/22
07:48
02/22/18
07:48
Conference/Events
Detroit Economic Club to hold a breakfast meeting »

Brenda Meller, Owner and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

MCS

Marcus

$26.10

1 (3.98%)

07:48
02/22/18
02/22
07:48
02/22/18
07:48
Earnings
Marcus reports Q4 EPS $1.21, consensus 38c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    May

PHX

Panhandle Oil & Gas

07:47
02/22/18
02/22
07:47
02/22/18
07:47
Initiation
Panhandle Oil & Gas initiated  »

Panhandle Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 11

    Mar

CRM

Salesforce

$114.48

0.13 (0.11%)

07:47
02/22/18
02/22
07:47
02/22/18
07:47
Recommendations
Salesforce analyst commentary  »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 28

    Feb

07:46
02/22/18
02/22
07:46
02/22/18
07:46
Conference/Events
FDA to co-host a workshop »

The FDA, American…

MLNX

Mellanox

07:44
02/22/18
02/22
07:44
02/22/18
07:44
Recommendations
Mellanox analyst commentary  »

Mellanox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

RDHL

RedHill Biopharma

$6.26

0.05 (0.81%)

07:44
02/22/18
02/22
07:44
02/22/18
07:44
Earnings
RedHill Biopharma reports Q4 EPS (26c), consensus (60c) »

Reports Q4 revenue $2M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 11

    Mar

07:43
02/22/18
02/22
07:43
02/22/18
07:43
Conference/Events
JPMorgan to hold a conference »

Korea Conference will be…

HSC

Harsco

$16.75

0.45 (2.76%)

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Earnings
Breaking Earnings news story on Harsco »

Harsco sees FY18 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Conference/Events
Deutsche Bank to hold a conference »

Indonesia Corporate Days…

ROKU

Roku

$51.10

-0.08 (-0.16%)

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Recommendations
Roku analyst commentary  »

Roku price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 21

    Mar

HSC

Harsco

$16.75

0.45 (2.76%)

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Earnings
Breaking Earnings news story on Harsco »

Harsco sees Q1 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

AKBA

Akebia

$14.31

0.69 (5.07%)

, CRSP

Crispr Therapeutics

$41.16

-0.45 (-1.08%)

07:41
02/22/18
02/22
07:41
02/22/18
07:41
Conference/Events
RBC Capital to hold a conference »

Global Healthcare…

AKBA

Akebia

$14.31

0.69 (5.07%)

CRSP

Crispr Therapeutics

$41.16

-0.45 (-1.08%)

RDUS

Radius Health

$37.71

-0.51 (-1.33%)

TYME

Tyme Technologies

$3.37

-0.06 (-1.75%)

HCA

HCA Healthcare

$100.35

-0.65 (-0.64%)

ARAY

Accuray

MDRX

Allscripts

$13.57

0.335 (2.53%)

ABEO

Abeona Therapeutics

$11.70

0.1 (0.86%)

SGEN

Seattle Genetics

$54.11

-0.05 (-0.09%)

INSY

Insys Therapeutics

$7.93

0.34 (4.48%)

SPPI

Spectrum

$20.51

0.21 (1.03%)

SPH

Suburban Propane

$24.10

-0.2 (-0.82%)

AIMT

Aimmune

$32.21

-2.75 (-7.87%)

DEPO

Depomed

$7.46

0.07 (0.95%)

KTWO

K2M Group

$19.09

-0.01 (-0.05%)

INOV

Inovalon

$11.68

-1.025 (-8.07%)

IMMU

Immunomedics

$16.38

0.16 (0.99%)

OVID

Ovid Therapeutics

$6.83

-0.2 (-2.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

  • 11

    Mar

  • 14

    Mar

  • 01

    May

  • 03

    May

  • 22

    Feb

HSC

Harsco

$16.75

0.45 (2.76%)

07:40
02/22/18
02/22
07:40
02/22/18
07:40
Earnings
Harsco reports Q4 EPS ex-items 20c, consensus 14c »

Reports Q4 revenue $455M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

WPC

W.P. Carey

$59.53

-0.73 (-1.21%)

07:40
02/22/18
02/22
07:40
02/22/18
07:40
Hot Stocks
W.P. Carey enters into 18-year triple net lease with Astellas Institute »

W. P. Carey has entered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

07:40
02/22/18
02/22
07:40
02/22/18
07:40
General news
Fed's Quarles anticipates further gradual tightening »

Fed's Quarles…

ROCK

Gibraltar Industries

$31.75

0.35 (1.11%)

07:39
02/22/18
02/22
07:39
02/22/18
07:39
Earnings
Gibraltar Industries sees FY18 adjusted EPS $1.96-$2.08, consensus $1.81 »

Gibraltar is providing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$109.06

-1.92 (-1.73%)

07:39
02/22/18
02/22
07:39
02/22/18
07:39
Recommendations
Chevron analyst commentary  »

Chevron weakness a buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.